Michael Shetzline, CMO,SVP,Head-Res&Drug: Ironwood Pharmaceuticals IRWD Sell · Filed 24/02/14

Trade details

Type: Insider sale
Amount: $588,538.32
Shares · price: 38,618 sh · $15.24 a share
Held after: 340,484 sh
Stock: Ironwood Pharmaceuticals IRWD
Person: Michael ShetzlineCMO,SVP,Head-Res&Drug
Trade date: 24/02/12
Filed: 24/02/14
Days to filing: 2 days

Sold 10.2% of holdings

Share of holding sold: 10.2%

Ironwood Pharmaceuticals trades, last 26 weeks

What else happened in Ironwood Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/13~24/03/13

Michael Shetzline's recent trades

Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$377.4K
83,306 sh
$377.4K
Filed 09/23
Traded 09/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$62.3K
17,012 sh
$62.3K
Filed 02/25
Traded 02/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$59.3K
15,570 sh
$59.3K
Filed 02/25
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$138K
29,937 sh
$138K
Filed 02/20
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$72.6K
41,269 sh
$72.6K
Filed 25/02/12
Traded 25/02/10